No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MOH240621C310000
- 10.50
- +2.00+23.53%
15min DelayClose May 31 15:59 ET
10.50High10.50Low
10.50Open8.50Pre Close1 Volume4 Open Interest310.00Strike Price1.05KTurnover28.11%IV2.04%PremiumJun 21, 2024Expiry Date4.58Intrinsic Value100Multiplier19DDays to Expiry5.92Time Value100Contract SizeAmericanOptions Type0.6191Delta0.0189Gamma28.60Leverage Ratio-0.2311Theta0.0960Rho17.71Eff Leverage0.2739Vega
Intraday
- 5D
- 1D
News
Express News | NYSE Order Imbalance 125256.0 Shares on Buy Side
Molina Health Is Maintained at Overweight by JP Morgan
Molina Health Is Maintained at Overweight by JP Morgan
Express News | JP Morgan Maintains Overweight on Molina Healthcare, Lowers Price Target to $420
Unveiling 11 Analyst Insights On Molina Healthcare
Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on Molina Healthcare (NYSE:MOH) in the last three months.The following table summarizes their rece
Supporting Youth Behavioral Health a Top Priority for Molina Healthcare of Nevada
Molina donates $50,000 to NAMI Western Nevada at its gala in Carson CityCARSON CITY, Nev.--(BUSINESS WIRE)--Molina Healthcare of Nevada ("Molina") recently donated $50,000 to NAMI Western Nevada at NA
JPMorgan Adjusts Price Target on Molina Healthcare to $420 From $435
Molina Healthcare (MOH) has an average outperform rating and a price target range of $354 to $442, according to analysts polled by Capital IQ.
Comments
The 13F filing for the hedge fund led by the late Jim Simons (RIP) just dropped and we got you covered
Here's a breakdown of the biggest moves:
🔴 SOLD (ranked by largest prev. portfolio %)
$Exxon Mobil(XOM.US$ : 0.70%
$Boeing(BA.US$ : 0.43%
$GE Aerospace(GE.US$ : 0.41%
$Alphabet-C(GOOG.US$ : 0.31%
$Netflix(NFLX.US$ : 0.31%
$Disney(DIS.US$ : 0.24%
🟢 NEW (ranked by portfolio %):
$Chevron(CVX.US$ : 0.52% ...
Here's a breakdown of the biggest moves:
🔴 SOLD (ranked by largest prev. portfolio %)
$Exxon Mobil(XOM.US$ : 0.70%
$Boeing(BA.US$ : 0.43%
$GE Aerospace(GE.US$ : 0.41%
$Alphabet-C(GOOG.US$ : 0.31%
$Netflix(NFLX.US$ : 0.31%
$Disney(DIS.US$ : 0.24%
🟢 NEW (ranked by portfolio %):
$Chevron(CVX.US$ : 0.52% ...
+1
16
RECAP
April rain better mean the stock market stops the pain by May: the market declined Tuesday, punctuated by the fall of fan favorite Tesla. The EV maker made less EV's than last year and dropped nearly 5%.
Stocks closed lower, the $S&P 500 Index(.SPX.US$ was recently down about 0.72%. $NASDAQ 100 Index(.NDX.US$ fell about 0.94%. $Dow Jones Industrial Average(.DJI.US$ fell 1%.
MACRO
Job openings recorded by JOLTS were just shy of expectations...
April rain better mean the stock market stops the pain by May: the market declined Tuesday, punctuated by the fall of fan favorite Tesla. The EV maker made less EV's than last year and dropped nearly 5%.
Stocks closed lower, the $S&P 500 Index(.SPX.US$ was recently down about 0.72%. $NASDAQ 100 Index(.NDX.US$ fell about 0.94%. $Dow Jones Industrial Average(.DJI.US$ fell 1%.
MACRO
Job openings recorded by JOLTS were just shy of expectations...
42
4
Recent insider selling at Molina Healthcare may hint at insiders believing the shares are overpriced. Despite profitability and profit growth, the absence of insider buying and recent selling could caution investors.
Analysts' sentiment remains steady post latest results, with a minor rise in revenue forecasts. Despite EPS missing estimates, earnings continue to be the value driver. Molina Healthcare's revenue growth rate is expected to surpass the industry.
1
Molina Healthcare's high P/E ratio is justified by its strong forecast growth, surpassing the wider market. Investors see insignificant potential for earnings deterioration, hence a lower P/E ratio isn't warranted. Share price drop in near future is unlikely.
Read more